X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB FRESENIUS KABI ONCO. UNICHEM LAB/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 22.1 22.1 99.8% View Chart
P/BV x 2.3 3.1 74.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 UNICHEM LAB   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
FRESENIUS KABI ONCO.
Mar-13
UNICHEM LAB/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs334176 189.8%   
Low Rs17479 221.7%   
Sales per share (Unadj.) Rs146.937.7 389.8%  
Earnings per share (Unadj.) Rs11.95.1 233.5%  
Cash flow per share (Unadj.) Rs16.26.7 240.8%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.142.5 247.1%  
Shares outstanding (eoy) m90.84158.23 57.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.73.4 51.2%   
Avg P/E ratio x21.425.0 85.5%  
P/CF ratio (eoy) x15.718.9 82.9%  
Price / Book Value ratio x2.43.0 80.8%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,07320,135 114.6%   
No. of employees `0005.71.2 492.4%   
Total wages/salary Rs m2,558703 363.8%   
Avg. sales/employee Rs Th2,352.55,176.2 45.4%   
Avg. wages/employee Rs Th450.9610.4 73.9%   
Avg. net profit/employee Rs Th190.4699.6 27.2%   
INCOME DATA
Net Sales Rs m13,3465,963 223.8%  
Other income Rs m19218 1,066.1%   
Total revenues Rs m13,5385,981 226.3%   
Gross profit Rs m1,6391,430 114.6%  
Depreciation Rs m390258 151.2%   
Interest Rs m29-26 -110.8%   
Profit before tax Rs m1,4121,216 116.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-35-68 51.8%   
Tax Rs m293342 85.5%   
Profit after tax Rs m1,080806 134.1%  
Gross profit margin %12.324.0 51.2%  
Effective tax rate %20.728.1 73.7%   
Net profit margin %8.113.5 59.9%  
BALANCE SHEET DATA
Current assets Rs m5,9795,102 117.2%   
Current liabilities Rs m2,4322,385 102.0%   
Net working cap to sales %26.645.6 58.4%  
Current ratio x2.52.1 115.0%  
Inventory Days Days63150 42.0%  
Debtors Days Days60113 53.3%  
Net fixed assets Rs m6,4035,148 124.4%   
Share capital Rs m182158 114.9%   
"Free" reserves Rs m9,2936,556 141.8%   
Net worth Rs m9,5486,732 141.8%   
Long term debt Rs m230952 24.2%   
Total assets Rs m12,84310,388 123.6%  
Interest coverage x50.0-45.8 -109.3%   
Debt to equity ratio x00.1 17.1%  
Sales to assets ratio x1.00.6 181.0%   
Return on assets %8.67.5 115.0%  
Return on equity %11.312.0 94.5%  
Return on capital %14.314.6 98.2%  
Exports to sales %29.274.5 39.2%   
Imports to sales %6.324.8 25.6%   
Exports (fob) Rs m3,9004,441 87.8%   
Imports (cif) Rs m8471,477 57.3%   
Fx inflow Rs m4,3565,298 82.2%   
Fx outflow Rs m1,1621,772 65.6%   
Net fx Rs m3,1943,525 90.6%   
CASH FLOW
From Operations Rs m1,1191,274 87.8%  
From Investments Rs m-853-1,204 70.9%  
From Financial Activity Rs m-334-196 170.4%  
Net Cashflow Rs m-68-126 54.1%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 15.1 0.3 5,033.3%  
FIIs % 3.0 9.6 31.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 9.1 348.4%  
Shareholders   20,176 42,599 47.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  PFIZER  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 21, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ORCHID PHARMA LTD COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS